BRPI0814256A2 - Inibidores de tetrahidropiranocromeno gama secretase - Google Patents

Inibidores de tetrahidropiranocromeno gama secretase

Info

Publication number
BRPI0814256A2
BRPI0814256A2 BRPI0814256-4A2A BRPI0814256A BRPI0814256A2 BR PI0814256 A2 BRPI0814256 A2 BR PI0814256A2 BR PI0814256 A BRPI0814256 A BR PI0814256A BR PI0814256 A2 BRPI0814256 A2 BR PI0814256A2
Authority
BR
Brazil
Prior art keywords
tetrahydropyrochyromene
secretase
inhibitors
range
range inhibitors
Prior art date
Application number
BRPI0814256-4A2A
Other languages
English (en)
Inventor
Wen-Lian Wu
Thomas A Bara
Duane A Burnett
John W Clader
Martin S Domalski
Yan Jin
Hubert B Josien
Hongmei Li
Xian Liang
Dmitri A Pissarnitski
Thavalakulamgara K Sasikumar
Jesse K Wong
Ruo Xu
Zhiqiang Zhao
Paul Mcnamara
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI0814256A2 publication Critical patent/BRPI0814256A2/pt
Publication of BRPI0814256A8 publication Critical patent/BRPI0814256A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
BRPI0814256A 2007-07-05 2008-07-01 Inibidores de tetrahidropiranocromeno gama secretase BRPI0814256A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94803307P 2007-07-05 2007-07-05
PCT/US2008/008192 WO2009008980A2 (en) 2007-07-05 2008-07-01 Tetrahydropyranochromene gamma secretase inhibitors

Publications (2)

Publication Number Publication Date
BRPI0814256A2 true BRPI0814256A2 (pt) 2015-02-03
BRPI0814256A8 BRPI0814256A8 (pt) 2016-02-10

Family

ID=39830164

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814256A BRPI0814256A8 (pt) 2007-07-05 2008-07-01 Inibidores de tetrahidropiranocromeno gama secretase

Country Status (16)

Country Link
US (1) US8664411B2 (pt)
EP (1) EP2435416B1 (pt)
JP (1) JP5240871B2 (pt)
KR (1) KR20100044197A (pt)
CN (1) CN101754960A (pt)
AR (1) AR067445A1 (pt)
AU (1) AU2008275735B2 (pt)
BR (1) BRPI0814256A8 (pt)
CA (1) CA2691542A1 (pt)
CL (1) CL2008001960A1 (pt)
CO (1) CO6270309A2 (pt)
EC (1) ECSP109845A (pt)
PE (1) PE20090435A1 (pt)
RU (1) RU2483061C2 (pt)
TW (1) TW200908959A (pt)
WO (1) WO2009008980A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080095885A (ko) 2006-01-20 2008-10-29 쉐링 코포레이션 벤젠설포닐-크로만, 티오크로만, 테트라하이드로나프탈렌 및 관련된 감마 세크라타제 억제제
WO2009011851A1 (en) 2007-07-17 2009-01-22 Schering Corporation Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
KR101755737B1 (ko) 2009-09-11 2017-07-07 프로비오드룩 아게 글루타미닐 사이클라제의 억제제로서 헤테로사이클릭 유도체
WO2012040444A2 (en) * 2010-09-24 2012-03-29 Bristol-Myers Squibb Company Treatment of patients with incipient alzheimer's disease
US8933116B2 (en) 2011-04-04 2015-01-13 Merck Sharp & Dohme Corp. Gamma secretase inhibitors
EP2753623A4 (en) * 2011-09-09 2015-01-28 Merck Sharp & Dohme GAMMA SECRETASE INHIBITORS
US9464103B2 (en) 2012-11-29 2016-10-11 Merck Sharp & Dohme Corp. Spirocyclic sulfones as gamma secretase inhibitors
CN104918938B (zh) * 2012-12-20 2017-08-15 詹森药业有限公司 新颖的作为γ分泌酶调节剂的三环3，4‑二氢‑2H‑吡啶并[1，2‑a]吡嗪‑1，6‑二酮衍生物
WO2014111457A1 (en) 2013-01-17 2014-07-24 Janssen Pharmaceutica Nv Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
AU2017356911A1 (en) 2016-11-09 2019-06-20 Bristol-Myers Squibb Company Tricyclic sulfones as ROR gamma modulators
CA3066077A1 (en) 2017-06-07 2018-12-13 Adrx, Inc. Tau aggregation inhibitors
CA3073062A1 (en) 2017-08-18 2019-02-21 Adrx, Inc. Tau aggregation peptide inhibitors
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020006626A (ko) 1999-02-26 2002-01-23 폴락 돈나 엘. 신규한 술폰아미드 화합물 및 그의 용도
FR2827590B1 (fr) * 2001-07-18 2003-10-24 Atuser Transbordeur de liquides alimentaires usages
GB0108591D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
AU2002324582B9 (en) * 2001-08-03 2006-02-16 Schering Corporation Novel gamma secretase inhibitors
RU2202370C1 (ru) * 2001-12-26 2003-04-20 Эпштейн Олег Ильич Нейропсихотропное лекарственное средство
GB0222833D0 (en) 2002-10-02 2002-11-06 Syngenta Ltd Chemical process
GB0223039D0 (en) * 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
US7410964B2 (en) * 2003-05-16 2008-08-12 Merck Sharp & Dohme Ltd. Cyclohexyl sulphones as gamma-secretase inhibitors
GB0317491D0 (en) * 2003-07-25 2003-08-27 Novartis Ag Organic compounds
DE102005062098A1 (de) * 2005-12-22 2007-06-28 Merck Patent Gmbh Oxaphenanthren-Derivate
KR20080095885A (ko) * 2006-01-20 2008-10-29 쉐링 코포레이션 벤젠설포닐-크로만, 티오크로만, 테트라하이드로나프탈렌 및 관련된 감마 세크라타제 억제제
TW200813054A (en) * 2006-06-02 2008-03-16 Elan Pharm Inc Fused, tricyclic sulfonamide inhibitors of gamma secretase
CA2742486A1 (en) 2008-11-13 2010-05-20 Schering Corporation Gamma secretase modulators

Also Published As

Publication number Publication date
JP5240871B2 (ja) 2013-07-17
AU2008275735B2 (en) 2014-03-27
RU2483061C2 (ru) 2013-05-27
WO2009008980A2 (en) 2009-01-15
BRPI0814256A8 (pt) 2016-02-10
AR067445A1 (es) 2009-10-14
AU2008275735A1 (en) 2009-01-15
KR20100044197A (ko) 2010-04-29
WO2009008980A3 (en) 2009-03-19
CL2008001960A1 (es) 2009-11-27
US8664411B2 (en) 2014-03-04
RU2010103716A (ru) 2011-08-10
EP2435416A2 (en) 2012-04-04
AU2008275735A2 (en) 2010-02-11
EP2435416B1 (en) 2016-03-30
CO6270309A2 (es) 2011-04-20
ECSP109845A (es) 2010-02-26
CA2691542A1 (en) 2009-01-15
TW200908959A (en) 2009-03-01
PE20090435A1 (es) 2009-04-18
CN101754960A (zh) 2010-06-23
JP2010532359A (ja) 2010-10-07
US20110236400A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
FR20C1031I2 (fr) Inhibiteurs de beta-lactamase
BRPI0814256A2 (pt) Inibidores de tetrahidropiranocromeno gama secretase
CY2017016I2 (el) Αναστολεις πρωτεασωματος
BRPI0815135A2 (pt) Derivados de azepina como inibidores de gama secretase.
BRPI0812170A2 (pt) Moduladores de gama secretase
CR10831A (es) INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
BRPI0810365A2 (pt) Inibidores de mlc-1 de indol 7-substituído
BRPI0820544A2 (pt) 4-pirazolil-n-arilpirimidin-2-aminas e pirazolil-n-heteroarilpirimidin-2-aminas como inibidores de janus cinase
BRPI0810832A2 (pt) Ferramenta de nível
BRPI1011129A2 (pt) métodos e compostos inibidores de janus cinase
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
BRPI0918846A2 (pt) inibidores de cinase heterocíclica
DK2024375T3 (da) Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
BRPI0719499A2 (pt) Composições de poliolefina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0622049A2 (pt) Estimativa de estado dinâmico
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0812825A2 (pt) Derivados ftalazinona como inibidores de parp-1
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0922880A2 (pt) compostos inibidores de quinase
BRPI0918564A2 (pt) inibidores
CR10879A (es) Cyclized derivatives as eg-5 inhibitors
BRPI0720547A2 (pt) Inibidores de metaloprotease derivada de heterocíclico
DK2066662T3 (da) Serinhydrolaseinhibitorer
BRPI0716198A2 (pt) Pirrolo-isoquinolinas como inibidores de cinase

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B25D Requested change of name of applicant approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

B25G Requested change of headquarter approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.